Exchange: NASDAQ·Updated 01:43 PM EDT
HURA logo

HURA TuHURA Biosciences Inc.

$2.10
$0.00
(0.00%)
Today
Reported EarningsAug 14
Mkt Cap$133.83M
Vol237,710.00

About HURA

TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. Its lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. The company was founded by Michael Lawman, Patricia Lawman and James A. Bianco on May 4, 2023 and is headquartered in Tampa, FL.
47

Neutral Sentiment

How do you feel about HURA?

Advertisement|Remove ads.